A randomized clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL (Docetaxel in Second-Line Treatment of Advanced Lung Cancer)

Authors :: Alfredo Falcone
Gallo, C. Gridelli C.
Di Maio, M.
Barletta, E.
Illiano, A.
Maione, P.
Salvagli, S.
Piantedosi, F. V.
Palazzolo, G.
Caffo, O.
Cerebelli, A.
Mozzanti, P.
Brancaccio, L.
Captano, M. A.
Isa, L.
Barbera, S.
Perrone On Behalf Of The Distal, F.
Source :: Università di Pisa-IRIS

Tools